Marta Wosińska

538 total citations
10 papers, 357 citations indexed

About

Marta Wosińska is a scholar working on Economics and Econometrics, Pharmacology and Marketing. According to data from OpenAlex, Marta Wosińska has authored 10 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 5 papers in Pharmacology and 4 papers in Marketing. Recurrent topics in Marta Wosińska's work include Pharmaceutical Economics and Policy (6 papers), Pharmaceutical industry and healthcare (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Marta Wosińska is often cited by papers focused on Pharmaceutical Economics and Policy (6 papers), Pharmaceutical industry and healthcare (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Marta Wosińska collaborates with scholars based in United States, Netherlands and Philippines. Marta Wosińska's co-authors include Janet Woodcock, Robert S. Huckman, Peter S. H. Leeflang, Ying Xie, Thomas J. Steenburgh, Min Ding, Sanjog Misra, Sridhar Narayanan, Xiaojing Dong and Natalie Mizik and has published in prestigious journals such as Journal of Marketing Research, The Journal of Economic Perspectives and Clinical Pharmacology & Therapeutics.

In The Last Decade

Marta Wosińska

9 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marta Wosińska United States	5	233	167	72	39	38	10	357
Ágnes Lublóy Hungary	12	198 0.8×	29 0.2×	43 0.6×	20 0.5×	18 0.5×	26	485
Mark A. Hurwitz United States	4	409 1.8×	186 1.1×	78 1.1×	21 0.5×	28 0.7×	5	471
Roberto Rodríguez‐Ibeas Spain	11	207 0.9×	31 0.2×	42 0.6×	23 0.6×	19 0.5×	29	309
Darren E. Ƶinner United States	12	189 0.8×	64 0.4×	13 0.2×	127 3.3×	11 0.3×	19	461
Mary K. Olson United States	12	283 1.2×	111 0.7×	12 0.2×	35 0.9×	43 1.1×	35	520
Ethan M.J. Lieber United States	10	162 0.7×	33 0.2×	33 0.5×	96 2.5×	37 1.0×	17	326
Christoph Schwierz Belgium	10	249 1.1×	40 0.2×	6 0.1×	18 0.5×	23 0.6×	22	368
Ana Xavier Portugal	7	232 1.0×	40 0.2×	6 0.1×	8 0.2×	61 1.6×	12	359
Nazila Yousefi Iran	10	107 0.5×	24 0.1×	6 0.1×	32 0.8×	33 0.9×	48	270
Glenn Sonnedecker United States	5	90 0.4×	79 0.5×	16 0.2×	30 0.8×	9 0.2×	35	257

Countries citing papers authored by Marta Wosińska

Since Specialization

Citations

This map shows the geographic impact of Marta Wosińska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Wosińska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Wosińska more than expected).

Fields of papers citing papers by Marta Wosińska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Wosińska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Wosińska. The network helps show where Marta Wosińska may publish in the future.

Co-authorship network of co-authors of Marta Wosińska

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Wosińska. A scholar is included among the top collaborators of Marta Wosińska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Wosińska. Marta Wosińska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Conti, Rena M. & Marta Wosińska. (2025). The Economics of Generic Drug Shortages: The Limits of Competition. The Journal of Economic Perspectives. 39(2). 79–102. 1 indexed citations

2.

Wosińska, Marta, et al.. (2021). Economics at the FTC: Multi-level Marketing and a Coal Joint Venture. Review of Industrial Organization. 59(4). 629–650.

3.

Liu, William & Marta Wosińska. (2017). The Landscape of Contract Manufacturing of Sterile Injectable Drugs: Who Is Making What, Where, and for Whom. Therapeutic Innovation & Regulatory Science. 51(4). 471–479. 2 indexed citations

4.

Wosińska, Marta, et al.. (2016). Patient Access in Restrictive Risk Management Programs: The Case of iPLEDGE. Therapeutic Innovation & Regulatory Science. 51(1). 16–23. 3 indexed citations

5.

Woodcock, Janet & Marta Wosińska. (2012). Economic and Technological Drivers of Generic Sterile Injectable Drug Shortages. Clinical Pharmacology & Therapeutics. 93(2). 170–6. 135 indexed citations

6.

Wosińska, Marta. (2005). Direct-to-Consumer Advertising and Drug Therapy Compliance. Journal of Marketing Research. 42(3). 323–332. 90 indexed citations

7.

Manchanda, Puneet, Dick R. Wittink, Andrew T. Ching, et al.. (2005). Understanding Firm, Physician and Consumer Choice Behavior in the Pharmaceutical Industry. Marketing Letters. 16(3-4). 293–308. 43 indexed citations

8.

Wosińska, Marta & Robert S. Huckman. (2004). Generic Dispensing And Substitution In Mail And Retail Pharmacies. Health Affairs. 23(Suppl1). W4–409. 17 indexed citations

9.

Wosińska, Marta. (2003). Advertising and Optimal Consumption Path: The Case of Prescription Drugs. SSRN Electronic Journal. 3 indexed citations

10.

Wosińska, Marta. (2002). Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products. SSRN Electronic Journal. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact